Home > Products > CD89 & EGFR
> Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (scIgG)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (scIgG) (CAT#: SCIGG-132)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD89 and anti-EGFR IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (scIgG) (SCIGG-132). Click the button below to contact us or submit your feedback about this product.